TrypLE™ Select is a recombinant enzyme free of animal-derived components, allowing the dissociation of a wide range of mammalian cells, including: CHO, HEK 293, A529, primary keratinocytes of human origin and stem cells.
TrypLE™ Select is a recombinant enzyme free of animal-derived components, allowing the dissociation of a wide range of mammalian cells, including: CHO, HEK 293, A529, primary keratinocytes of human origin and embryonic stem cells. We propose various formulations of TrypLE™ for a wide range of cell culture applications.
Compared to trypsin and other dissociation reagents, Gibco™ TrypLE™ Select is:
• Non-aggressiveness for cells — preserves the health of cells to achieve reproducible results
• Stable at room temperature — convenient to use
• Easy to use — integrates directly with existing protocols, without any inactivation required
• Animal-derived component free (AOF) — pure, homogeneous and effective
>TrypLE™ Select is amended as follows:
The formulation of TrypLE™ solutions is available, although we kept the concentration of the enzyme confidential.
Non-aggressive cells
Like trypsin, TrypLE™ Select clives the lateral peptide bonds of the carboxylic extremities of lysine and lysine. The exceptional purity of TrypLE™ Select nevertheless increases specificity by the action of a single enzyme. This reduces damage caused by the cleavage of several enzymes in trypsin and other extracts.
Stability at room temperature
TrypLE™ Select is stable at room temperature and ready for use. TrypLE™ Select cell dissociation reagents remain stable for 24 months at room temperature or 2 at 8°C, making storage and handling easier and more convenient.
TrypLE™ Select can be substituted for trypsin in existing protocols. In addition, the TrypLE™ Select only deactivates dilution, thus avoiding the need for trypsin inhibitors, such as SVF.
Animal origin-free
Unlike porcine trypsin and other enzymes, TrypLE™ Select is free of animal components and is formulated on dedicated equipment for this purpose.
Customers using Gibco™ TrypLE™ Select in a manufacturing process, who have submitted an application to the FDA, may request a letter of authorization to refer to the master file of Type II medicines.
Manufacturing and quality system in accordance with BPFa
Gibco™ TrypLE™ Select is manufactured in a BPFa-compliant facility located in Grand Island, New York. The site is licensed by FDA as a manufacturer of medical devices and is certified as ISO 13485.